#heart-disease

#heart-disease

Krauss's research shows that saturated fat is relatively neutral compared with what scientists have believed in the past. His studies have shown that reducing saturated fat intake is only beneficial if you replace it with the right things. Replacing saturated fats with unsaturated fats, like olive oil and polyunsaturated fats from other plant sources can really improve metabolic health and reduce heart disease risk, but that's not saying that saturated fat is necessarily harmful.

Being overweight has long been linked to heart conditions and type 2 diabetes, but even people who look thinner could be at risk, researchers suggest. A new study led by researchers at McMaster University in Ontario, Canada, explains there is such a thing as being skinny-fat - someone who appears to be healthy and slim but in fact has hidden fat deep inside their organs.

It is past time for women's health to move beyond "boobs and tubes" - as one expert termed the field's reproductive focus - to address the disparities and prejudice that have hindered medical providers from effectively treating more than half of the population. That's according to experts who gathered for a symposium held recently at the Radcliffe Institute for Advanced Study examining persistent gaps between men's and women's healthcare.

Men appear to be dying disproportionately from preventable diseases and conditions way more than women, and in many cases it's their own damn fault: because they're refusing to go to the doctor until it's too late. In interviews with the New York Times, doctors and public health experts expressed concerns with the state of men's preventative care, which they say many chaps tend to ignore - to their own peril.

Recent research indicates that men are more than twice as likely to die from takotsubo cardiomyopathy, despite being diagnosed less frequently than women.

Measuring Lp(a) can help identify someone who should be paying more attention to their cardiovascular risks, leveraging personal genetics for better health assessments.

In 2004-2005, new regulations mandated full disclosure of clinical trial data, allowing independent researchers to analyze statins' primary data, revealing exaggerated benefits.